SITC 2024 Advances in Cancer ImmunotherapyTM Programs

By SITC Staff

Staying at the forefront of clinical training and education is critical for health care professionals.  Designed to reach clinical oncologists, advanced practitioners and other allied health professionals, SITC’s upcoming 2024 ACI educational series offers a unique opportunity for in-depth clinical training across various disease states and topics. Gain a comprehensive understanding of fundamental cancer immunotherapy principles and access timely updates on the latest clinical advances in the field, including data from recent scientific meetings and clinical trials.

ACI program attendees will understand how to seamlessly integrate immunotherapy into clinical practice with insights from leading authorities in tumor immunology and cancer immunotherapy. The ACI educational series offers an overview of common approaches to cancer immunotherapy and their related mechanism. ACI programs also offer a deep dive into practical application, immune-related adverse events and future trends, ensuring that attendees leave with actionable insights that directly impact clinical practice.

Advance your education with a comprehensive and immersive program that translates into improved patient care and clinical outcomes. All ACI programs are certified for CME, CNE, CPE and/or MOC credits.

2024 ACI programs

The 2024 ACI series schedule includes:

• ACI: A Focus on Surgery | Saturday, March 23 Live at SSO 2024 | Atlanta
• ACI: A Focus on Breast Cancer | Friday, March 29 | Live via Zoom
• ACI: A Focus on Cellular Therapies, T Cell Engagers and TIL Therapies | Tuesday, April 16 | Live via Zoom
• ACI: A Focus on Toxicity Management | Tuesday, May 14 | Live via Zoom
• ACI: A Focus on Genitourinary Cancers | Tuesday, June 11 | Live via Zoom
• ACI: A Focus on Lung Cancers | Tuesday, June 25 | Live via Zoom
• ACI: A Focus on Hematologic Malignancies | Wednesday, September 11 | Live via Zoom
• ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines | Wednesday, October 9 | Live via Zoom

Program highlights

The 2024 ACI educational series offers attendees:

• Overview of common approaches to cancer immunotherapy and their related mechanisms
• Timely updates on the latest clinical advances in the field, including data from recent scientific meetings and clinical trials
• Dedicated opportunities for clinicians to ask questions and receive direction on difficult cases
• Strategies for addressing the practical barriers to implementing immunotherapy (operations, reimbursement and management of emerging toxicities)

Learn more about the program.

The information provided here is for your convenience only. ASTRO does not make any claims about the suitability or quality of the programs discussed.